ASHTON PRUETT: Open Payments
NPI 1851889117 · ONAWA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 89 payments from 20 companies in 2025. Trend: 2023 $427 · 2024 $732 · 2025 $1,377
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $310 |
| Novo Nordisk Inc | 10 | $149 |
| Lundbeck LLC | 9 | $146 |
| Teva Pharmaceuticals USA, Inc. | 9 | $138 |
| Lilly USA, LLC | 9 | $130 |
| Astellas Pharma US Inc | 5 | $84 |
| PFIZER INC. | 4 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: REXULTI, AUSTEDO XR, MOUNJARO, VRAYLAR, Veozah, QULIPTA, NURTEC ODT, Ozempic.
Industry payments across IA — which companies pay providers there.
